• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测支气管肺泡灌洗液中的半乳甘露聚糖对血液病患者侵袭性曲霉菌感染的诊断作用——影响检测性能的因素分析。

Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.

机构信息

Department of Internal Medicine - Hematology and Oncology, Masaryk University and University Hospital Brno, Jihlavska 20, 625 00 Brno, Czech Republic.

出版信息

Int J Infect Dis. 2011 Dec;15(12):e874-81. doi: 10.1016/j.ijid.2011.09.011. Epub 2011 Oct 30.

DOI:10.1016/j.ijid.2011.09.011
PMID:22040924
Abstract

BACKGROUND

We evaluated the performance of a galactomannan (GM) assay in bronchoalveolar lavage (BAL) fluid compared to serum samples for the diagnosis of invasive pulmonary aspergillosis (IPA) in patients with hematological diseases.

METHODS

Two hundred and fifty-five bronchoscopies were performed on 230 patients. Bronchial and alveolar samples from BAL fluid as well as serum samples were analyzed in the GM assay.

RESULTS

Twenty-eight cases of IPA (11%) were diagnosed. The sensitivity, specificity, positive predictive value, and negative predictive value of the GM assay using a cut-off of 0.5 were 57.1%, 99.3%, 94.1%, and 92.5%, respectively, for the alveolar sample; 44.0%, 99.3%, 91.7%, and 91.4%, respectively, for the bronchial sample; and 60.7%, 100%, 100%, and 92.9%, respectively, for serum. The highest sensitivity (78.6%) with good specificity (98.6%) was obtained with a 'triple detection' of GM in bronchial, alveolar, and serum samples. Neutropenia and antifungal therapy for only 24h increased the sensitivity, while antifungal treatment for ≥ 2 days decreased assay performance. Moreover, a trend towards a higher volume of aspirated fluid in GM-negative BAL (p=0.092) was observed.

CONCLUSIONS

In contrast to recently published data, we found only moderate sensitivity, but high specificity and high positive predictive value of the detection of GM in BAL fluid. In addition, neutropenia, antifungal therapy, and BAL standardization affected GM assay performance.

摘要

背景

我们评估了半乳甘露聚糖(GM)检测在支气管肺泡灌洗液(BAL)与血清样本中的性能,以用于诊断血液系统疾病患者的侵袭性肺曲霉病(IPA)。

方法

对 230 名患者进行了 255 次支气管镜检查。分析了支气管肺泡灌洗液(BAL)和血清样本中的 GM 检测。

结果

诊断出 28 例 IPA(11%)。GM 检测的肺泡样本的截止值为 0.5 时,灵敏度、特异性、阳性预测值和阴性预测值分别为 57.1%、99.3%、94.1%和 92.5%;支气管样本分别为 44.0%、99.3%、91.7%和 91.4%;血清样本分别为 60.7%、100%、100%和 92.9%。支气管、肺泡和血清样本 GM 的“三重检测”获得了最高的灵敏度(78.6%)和良好的特异性(98.6%)。中性粒细胞减少症和仅 24 小时的抗真菌治疗增加了检测的灵敏度,而≥2 天的抗真菌治疗则降低了检测的性能。此外,GM 阴性 BAL 中抽吸液体积较大的趋势(p=0.092)。

结论

与最近发表的数据相比,我们发现 GM 在 BAL 中的检测灵敏度仅为中等,但特异性和阳性预测值较高。此外,中性粒细胞减少症、抗真菌治疗和 BAL 标准化会影响 GM 检测的性能。

相似文献

1
Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.检测支气管肺泡灌洗液中的半乳甘露聚糖对血液病患者侵袭性曲霉菌感染的诊断作用——影响检测性能的因素分析。
Int J Infect Dis. 2011 Dec;15(12):e874-81. doi: 10.1016/j.ijid.2011.09.011. Epub 2011 Oct 30.
2
Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.支气管肺泡灌洗半乳甘露聚糖对侵袭性肺曲霉病高危患者预后的影响
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S86-93.
3
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.支气管肺泡灌洗液半乳甘露聚糖检测有助于血液恶性肿瘤和造血干细胞移植受者侵袭性肺曲霉病的诊断。
Biol Blood Marrow Transplant. 2011 Jul;17(7):1043-50. doi: 10.1016/j.bbmt.2010.11.013. Epub 2010 Nov 16.
4
Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.支气管肺泡灌洗液中曲霉菌半乳甘露聚糖抗原检测对侵袭性肺曲霉病的诊断价值。
J Infect. 2010 Dec;61(6):492-8. doi: 10.1016/j.jinf.2010.08.014. Epub 2010 Sep 15.
5
Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.半乳甘露聚糖在中性粒细胞减少的侵袭性曲霉病患者中的临床应用及预后价值
Pathol Biol (Paris). 2012 Dec;60(6):357-61. doi: 10.1016/j.patbio.2011.10.011. Epub 2011 Dec 10.
6
Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.血液恶性肿瘤患者支气管肺泡灌洗液半乳甘露聚糖检测的临床实用性和预后价值。
Diagn Microbiol Infect Dis. 2010 Oct;68(2):132-9. doi: 10.1016/j.diagmicrobio.2010.03.017.
7
Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.支气管肺泡灌洗液中半乳甘露聚糖检测对肺移植受者侵袭性曲霉菌病的诊断。
Transplantation. 2010 Aug 15;90(3):306-11. doi: 10.1097/TP.0b013e3181e49bc1.
8
Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.免疫功能低下患者支气管肺泡灌洗液半乳甘露聚糖抗原检测的效用。
Mycoses. 2013 Sep;56(5):552-8. doi: 10.1111/myc.12074. Epub 2013 Mar 18.
9
Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.支气管肺泡灌洗液半乳甘露聚糖检测对儿童侵袭性肺曲霉病的诊断价值。
Pediatr Pulmonol. 2013 Aug;48(8):789-96. doi: 10.1002/ppul.22670. Epub 2012 Sep 4.
10
Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.曲霉半乳甘露聚糖和 PCR 在支气管肺泡灌洗液中用于诊断血液恶性肿瘤患者侵袭性肺曲霉病的临床效用。
Diagn Microbiol Infect Dis. 2014 Jul;79(3):322-7. doi: 10.1016/j.diagmicrobio.2014.03.020. Epub 2014 Mar 29.

引用本文的文献

1
An Observational Cohort Study of Bronchoalveolar Lavage Fluid Galactomannan and Culture Positivity in Patients Requiring Mechanical Ventilation.一项针对需要机械通气患者的支气管肺泡灌洗液体半乳甘露聚糖及培养阳性率的观察性队列研究。
Open Forum Infect Dis. 2025 Feb 15;12(3):ofaf090. doi: 10.1093/ofid/ofaf090. eCollection 2025 Mar.
2
Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases-a debate.打破常规:挑战侵袭性真菌病临床试验反应定义的现状——一场辩论
J Antimicrob Chemother. 2024 Aug 1;79(8):1786-1793. doi: 10.1093/jac/dkae158.
3
Metagenomic next-generation sequencing for detecting pneumonia in immunocompromised patients: a retrospective study.
免疫功能低下患者肺炎的宏基因组下一代测序检测:一项回顾性研究。
Front Cell Infect Microbiol. 2023 Dec 22;13:1209724. doi: 10.3389/fcimb.2023.1209724. eCollection 2023.
4
Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience.泊沙康唑预防和抗真菌治疗对血液恶性肿瘤合并发热性中性粒细胞减少症患者 BAL GM 检测性能的影响:真实世界经验。
Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):33-43. doi: 10.1007/s10096-023-04686-7. Epub 2023 Nov 1.
5
Galactomannan-Antigen Testing from Non-Directed Bronchial Lavage for Rapid Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients: A Proof-of-Concept Study.非定向支气管灌洗半乳甘露聚糖抗原检测用于危重症患者侵袭性肺曲霉病的快速诊断:一项概念验证研究
Diagnostics (Basel). 2023 Mar 21;13(6):1190. doi: 10.3390/diagnostics13061190.
6
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases.侵袭性真菌病的非侵入性检测与替代标志物
Open Forum Infect Dis. 2022 Mar 4;9(6):ofac112. doi: 10.1093/ofid/ofac112. eCollection 2022 Jun.
7
Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis.支气管肺泡灌洗液半乳甘露聚糖检测对侵袭性曲霉病的诊断准确性。
Biomed Res Int. 2020 Nov 30;2020:5434589. doi: 10.1155/2020/5434589. eCollection 2020.
8
Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance.支气管肺泡灌洗液和血清 1,3-β-D-葡聚糖检测在血液病患者侵袭性肺曲霉病诊断中的作用:影响检测性能的因素。
Sci Rep. 2020 Oct 21;10(1):17963. doi: 10.1038/s41598-020-75132-3.
9
Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.免疫功能低下患者侵袭性曲霉病支气管肺泡灌洗中半乳甘露聚糖的检测
Cochrane Database Syst Rev. 2019 May 20;5(5):CD012399. doi: 10.1002/14651858.CD012399.pub2.
10
A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit.一种用于预测重症监护病房侵袭性肺曲霉病的新型诊断评分模型。
Saudi Med J. 2019 Feb;40(2):140-146. doi: 10.15537/smj.2019.2.22940.